$GHMP news on new agreement with well established Barlean's

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
384
$GHMP news on new agreement with well established Barlean's for marketing of wellness products:

Good Hemp Enters Production Agreement With Barlean's

CORNELIUS, N.C., March 12, 2021 /PRNewswire/ -- Good Hemp, Inc. (OTC PINK: GHMP) is pleased to announce an executed production agreement with Barlean's, a producer of healthy oils and other dietary supplements for nearly 30 years.

Barlean's will oversee the production of the uniquely blended Good Hemp Wellness CBD Softgel that will serve customers in the health and wellness market that's touted to be valued at $24B. As previously announced, Dr. Jason Minsky, DC, will act as Managing Director of the company's new partially-owned subsidiary, which will distribute the softgels.

The unique softgel formulation contains 25mg of cannabidiol and a fast-acting, self-emulsifying formulation that is proprietary to Barlean's and has been shown in internal studies to increase absorption into the bloodstream by 200%. Good Hemp has selected this formulation with chiropractors and their patients in mind, and the company hopes to distribute the softgels to a network of chiropractors throughout the US.

"We are excited to work with Barlean's on our Good Hemp Wellness rollout," said Chris Chumas, Director of Good Hemp. "After evaluating multiple production facilities, Barlean's experience and success in the oils and supplement manufacturing industry rose to the top, and we believe that our product will be well received by providers across the country."

Good Hemp Wellness plans to focus on delivering the benefits of CBD to patients struggling with the debilitating symptoms of common ailments. In addition to collaborating with Barlean's, Good Hemp Wellness has begun the process of being certified by The U.S. Hemp Authority for its CBD Softgel products. The U.S. Hemp Authority Certification Program is the hemp industry's initiative to provide high standards, best practices, and self-regulation, giving consumers and retailers confidence in hemp and CBD products.

About Barlean's -

Barlean's is a mission-driven, family-owned company that's been making healthy oils and supplements in the Pacific Northwest for nearly 30 years. Founded in 1989 as a maker of premium flax oils, Barlean's has grown to produce over 70 different products sold around the world.

In 2013, owner Bruce Barlean implemented what he calls the "Pathway to a Better Life" philosophy within the company. Since that time, a significant portion of company products has been shared with organizations dedicated to improving people's health and well-being both locally and around the globe. In addition, Barlean's is dedicated to helping create a pathway to a better life for people along the supply chain and beyond – from fair prices for farmers and suppliers to treating employees, retailers, and even competitors with fairness and respect.

About Good Hemp Products -

Good Hemp, Inc.'s beverage lineup consists of Good Hemp Fizz and Canna Hemp, functional carbonated beverages infused with natural ingredients and made with hemp seed oil, which is categorized as "GRAS" (under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act, and therefore not subject to FDA review and approval). Good Hemp 2oh! is a line of naturally flavored waters infused with 10mg of THC-free hemp extract and prebiotic fiber. These products are available online from Amazon and goodhempinc.com

Good Hemp Wellness will be launching with a line of cannabidiol gel caps consisting of a fast-acting, proprietary, self-emulsifying formulation aimed at providing consumers with American-made CBD products they can trust.

Diamond Creek, which is currently under a letter of intent to be acquired by Good Hemp, manufactures ionized 9.5pH high alkaline natural spring water, sourced from the highest quality, award-winning springs in Ohio, Pennsylvania, and Tennessee. Available in three sizes: 1 gallon, 1 liter and 500 mL bottles. Visit www.diamondcreekwater.com for more information.

FDA Disclaimer -

The CBD softgel and beverage products and the statements made about them in this press release have not been evaluated by the United States Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement -

This press release may contain forward-looking information that involve a number of risks and uncertainties made pursuant to Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act" and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things, the company's business plans and the company's growth strategy and operating strategy. Words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "would," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of numerous and varied factors. Good Hemp, Inc. does not undertake to update any forward-looking statements except as required by applicable law. All subsequent written and oral forward-looking statements attributable to the company or any person acting on behalf of the company are expressly qualified in their entirety by the cautionary statements referenced above.

Contact:

Good Hemp, Inc.

+1 (800) 947-9197

contact@goodhemplivin.com


SOURCE Good Hemp, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 200

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 245

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 238

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 286

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 151

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Avacta Therapeutics Showcases Promising FAP-Dox Data at ESMO

Updated Category News Views 196

Avacta Therapeutics Presents FAP-Dox Data at International Congress Avacta Therapeutics, a pioneering life sciences company, is set to present an exciting update regarding their innovative drug FAP-Dox (AVA6000) at an esteemed international oncology congress. This event will spotlight groundbreaking research and clinical advancements in targeted cancer treatments that can...

Continue Reading
Qvinci and Harmonyze Join Forces to Revolutionize Franchise Coaching

Updated Category News Views 163

Strategic Collaboration Between Qvinci and Harmonyze In a remarkable development, Qvinci Software, renowned for its innovative franchise financial performance solutions, has announced a pivotal partnership with Harmonyze, an AI-driven performance coaching platform. This collaboration is designed to assist franchisors in transforming intricate financial insights into...

Continue Reading
Citi Remains Optimistic on Capgemini Amid Margin Growth

Updated Category News Views 198

Outlook for Capgemini Stock Citi analyst Balajee Tirupati has recently made adjustments to the price target for Capgemini SE (CAP:FP) (OTC: CAPMF), reducing it to €215 from €225. Despite this revision, Citi has maintained a positive stance, continuing to endorse a Buy rating for Capgemini's stock. Weaker Third-Quarter Update Capgemini's recent third-quarter report for...

Continue Reading
Beyond Oil Marks Key Milestone with Initial Shipment to T&J Oil

Updated Category News Views 252

Beyond Oil's Successful Expansion into the Australian Market Following its commitment to health and sustainability, Beyond Oil Ltd. (CSE: BOIL, OTCQB: BEOLF) has successfully delivered its first shipment of 5.4 tonnes of proprietary oil treatment products to T&J Oil Pty Ltd. This marks an important leap for the company as it steps into the Australian distribution arena,...

Continue Reading
Donaldson Partners with the Special Olympics to Inspire Change

Updated Category News Views 87

Donaldson's Commitment to Community Engagement Donaldson Company, Inc. (NYSE: DCI), a leader in innovative filtration solutions, has taken a significant step towards community engagement by announcing its partnership with the 2026 Special Olympics USA Games. This event is set to create a platform for inclusion, offering athletes with diverse abilities an opportunity to...

Continue Reading